Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 343.50 GBp
Change Today -1.50 / -0.43%
Volume 8.4K
OPTS On Other Exchanges
Symbol
Exchange
London
OTC US
As of 5:16 AM 03/30/15 All times are local (Market data is delayed by at least 15 minutes).

optos plc (OPTS) Snapshot

Open
343.75 GBp
Previous Close
345.00 GBp
Day High
344.00 GBp
Day Low
343.50 GBp
52 Week High
03/20/15 - 351.00 GBp
52 Week Low
05/2/14 - 148.00 GBp
Market Cap
251.2M
Average Volume 10 Days
84.0K
EPS TTM
0.12 GBp
Shares Outstanding
73.1M
EX-Date
--
P/E TM
43.6x
Dividend
--
Dividend Yield
--
Current Stock Chart for OPTOS PLC (OPTS)

Related News

No related news articles were found.

optos plc (OPTS) Related Businessweek News

No Related Businessweek News Found

optos plc (OPTS) Details

Optos plc, a retinal imaging company, provides diagnostic and treatment devices to healthcare professionals worldwide. Its medical devices produce ultra-widefield, high resolution digital images of approximately 82% of the retina, which provide clinical information by facilitating the early detection, management, and treatment of disorders and diseases evidenced in the retina, such as retinal detachments and tears, glaucoma, diabetic retinopathy, and age-related macular degeneration. The company’s retinal devices are also used for the treatment of non-eye diseases, including hypertension and cancers. Its ultra-widefield imaging devices include the P200 and 200Dx devices, which are concentrated on wellness screening carried out in primary care; the P200C devices that are designed to serve the need for clinical imaging capabilities and standards in secondary care within the ophthalmology market and at optometric practices; and the P200MA and 200Tx devices, which support the medical care market. The company also offers optical coherence tomography (OCT) imaging products, such as Optos OCT SLO system, which combines spectral OCT imaging with a confocal scanning ophthalmoscope in an instrument that allows eye care professionals to diagnose and track changes in the retinal diseases and their treatments; Microperimetry that assesses the visual function of a specific area of the retina and fovea, and correlates to the OCT structural changes; and AC Cornea Lens, which provides high-resolution spectral OCT imaging of the cornea and angle. In addition, it provides OCT diagnostic devices and optical ultrasound scanners that are used in the diagnosis and management of eye disease and conditions; and medical surgical devises and diagnostic instruments, as well as develops retinal imaging software. The company sells its products directly or through arrangements with distributors. The company was founded in 1992 and is headquartered in Dunfermline, the United Kingdom.

391 Employees
Last Reported Date: 01/20/15
Founded in 1992

optos plc (OPTS) Top Compensated Officers

Chief Executive Officer and Executive Directo...
Total Annual Compensation: $867.0K
Chief Financial Officer, Company Secretary an...
Total Annual Compensation: $533.0K
Compensation as of Fiscal Year 2014.

optos plc (OPTS) Key Developments

Optos plc, Annual General Meeting, Feb 19, 2015

Optos plc, Annual General Meeting, Feb 19, 2015.

Optos Seeks Acquisitions

Optos plc seeks acquisitions. Chief executive Roy Davis acknowledged that put the business in a good position if acquisition opportunities came up but said the focus was on growing in its existing markets and through its current device portfolio. He added that if there are things that inherently add value to Optos overall we will look at those as and when they occur.

Optos plc Announces Preliminary Consolidated Earnings Results for the Year Ended September 30, 2014

Optos plc announced preliminary consolidated earnings results for the year ended September 30, 2014. For the year, the company reported revenue of $168.9 million against $158.2 million a year ago. Operating profit was $10.0 million against $6.9 million a year ago. Profit from continuing operations before taxation was $12.2 million or 11.3 cents per diluted share against $9.5 million or 8.6 cents per diluted share a year ago. Net profit for the year attributable to equity holders of the parent was $8.5 million or 16.2 cents per diluted share against $6.4 million or 12.8 cents per diluted share a year ago. Net cash outflows from operating activities were $2.9 million against $19.2 million a year ago. Purchase of property, plant and equipment was $2.4 million against 3.8 million a year ago. Net book value as at September 30, 2014 was $5.5 million against $9.0 million a year ago. Net debt as at September 30, 2014 was $12.2 million against $39.4 million a year ago. Improved profitability and inventory reduction helped reduce net debt by 69%. The revenue growth combined with focus on cost control has delivered a 100% improvement in adjusted profit before tax to $18.5 million from $9.2 million a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OPTS:LN 343.50 GBp -1.50

OPTS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for OPTS.
View Industry Companies
 

Industry Analysis

OPTS

Industry Average

Valuation OPTS Industry Range
Price/Earnings 45.3x
Price/Sales 2.2x
Price/Book 2.7x
Price/Cash Flow 44.2x
TEV/Sales 2.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OPTOS PLC, please visit www.optos.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.